Kristin Bloink is the Vice President of Global Regulatory Affairs and Pharmacovigilance at Elanco Animal Health. In this role, she leads the efforts to register new innovative products across many indications for 6 species and provide product stewardship for commercial products sold in 90+ countries. This scope covers a mix of internally and externally sourced innovation, and all major technology platforms (to include small molecule, biopharma, vaccine technologies, and nutritional health). She also Chairs the corporate non-profit, Elanco Foundation, focused on food security and human animal bond initiatives globally. Kristin has over 30 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private, academic as well as the military sectors. Past employers, with leadership roles have included: University of Michigan - Cranial Base Program, United States Army, Novartis Animal Health, and several private hospitals/clinician groups in both human and veterinary medicine. Outside of Elanco, she helps support the ongoing need for veterinary basic and applied science research by serving on the Board of Directors of the American Kennel Club, Canine Health Foundation and several university advisory boards in the areas of public health and agriculture. She is also on the Board of Directors of Pet Partners and a member of the Health, Education and Genetics Committee of the Golden Retriever Club of America. She earned a BS in Human Medicine from the University of Iowa, a MPH from the University of Michigan, and a DVM from Michigan State University. She is a Diplomate of the American College of Veterinary Preventative Medicine.